|
- COPD Inhaler | ANORO ELLIPTA (umeclidinium and vilanterol inhalation . . .
Learn more about ANORO ELLIPTA, a once-daily prescription medication to treat chronic obstructive pulmonary disease See Full Safety Prescribing Information
- Risks Side Effects | ANORO ELLIPTA (umeclidinium and vilanterol . . .
If you take too much ANORO ELLIPTA, call your healthcare provider or go to the nearest hospital emergency room right away if you have any unusual symptoms, such as worsening shortness of breath, chest pain, increased heart rate, or shakiness
- About ANORO | ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder)
Once-daily ANORO is a prescription medicine used long term to treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis, emphysema, or both, for better breathing and to reduce the number of flare-ups ANORO is not for asthma ANORO is not used to relieve sudden symptoms of COPD and won't replace a rescue inhaler
- How To Use ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder)
Follow instructions for using your ANORO ELLIPTA inhaler correctly See Full Safety Prescribing Information
- ANORO Results | ANORO ELLIPTA (umeclidinium and vilanterol inhalation . . .
Find clinical study results for ANORO ELLIPTA, studied in patients with moderate to severe COPD See Full Safety Prescribing Information
- COPD Patient Stories | ANORO ELLIPTA (umeclidinium and vilanterol . . .
Hear from real COPD patients about their experiences before and after taking ANORO ELLIPTA See Full Safety Prescribing Information
- Resources | ANORO ELLIPTA (umeclidinium and vilanterol Inhalation powder)
Once-daily ANORO is a prescription medicine used long term to treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis, emphysema, or both, for better breathing and to reduce the number of flare-ups
- The Impact of COPD | ANORO ELLIPTA (umeclidinium and vilanterol . . .
Once-daily ANORO is a prescription medicine used long term to treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis, emphysema, or both, for better breathing and to reduce the number of flare-ups
|
|
|